Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways Enlace: https://www.sciencedirect.com/science/article/pii/S0166354219302347?dgcid=api_sd_search-api-endpoint Editoriales ScienceDirect